GW 493838
Alternative Names: 493838Latest Information Update: 02 Aug 2023
At a glance
- Originator GlaxoSmithKline
- Class Analgesics
- Mechanism of Action Adenosine A1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Lipid metabolism disorders; Neuropathic pain
Most Recent Events
- 06 Dec 2005 Discontinued - Phase-II for Lipid metabolism disorders in USA (unspecified route)
- 30 Nov 2004 Discontinued - Phase-II for Neuropathic pain in United Kingdom (unspecified route)
- 10 Dec 2003 Phase-II clinical trials in Lipid metabolism disorders in USA (unspecified route)